TY - JOUR
T1 - Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2
AU - on behalf of the International Chromosome 22q11.2, International 22q11.2 Brain and Behavior Consortia
AU - Guo, Tingwei
AU - Diacou, Alexander
AU - Nomaru, Hiroko
AU - McDonald-McGinn, Donna M.
AU - Hestand, Matthew
AU - Demaerel, Wolfram
AU - Zhang, Liangtian
AU - Zhao, Yingjie
AU - Ujueta, Francisco
AU - Shan, Jidong
AU - Montagna, Cristina
AU - Zheng, Deyou
AU - Crowley, Terrence B.
AU - Kushan-Wells, Leila
AU - Bearden, Carrie E.
AU - Kates, Wendy R.
AU - Gothelf, Doron
AU - Schneider, Maude
AU - Eliez, Stephan
AU - Breckpot, Jeroen
AU - Swillen, Ann
AU - Vorstman, Jacob
AU - Zackai, Elaine
AU - Gonzalez, Felipe Benavides
AU - Repetto, Gabriela M.
AU - Emanue, Beverly S.
AU - Bassett, Anne S.
AU - Vermeesch, Joris R.
AU - Marshall, Christian R.
AU - Morrow, Bernice E.
N1 - Funding Information:
We would like to thank the families with 22q11.2DS who provided DNA and clinical information. We acknowledge the Genomics and Molecular Cytogenetics Cores at Einstein. We also acknowledge Mark Zeffren, Nousin Haque and Antoneta Preldakaj for project management and John Bruppacher, Dan Arroyo, Michael Gleeson, Dominique Calandrillo and Frédérique Bena for technical support at Einstein. We also greatly appreciate the laboratory effort of Dr. Frédérique Bena who works with SE and SEA (Institute of Genetics and Genomics of Geneva, Switzerland). NIH R01 HL084410 (BSE, BEM, DMM, TG, TW), P01 HD070454 (BSE, BEM, DMM, TG, TW, HN, LZ, DZ, YZ, TBC), U01 MH101720 (TG, AD, DMM, MH, WD, YZ, FU, LK-W, CEB, WRK, DG, MS, SE, JB, AS, JV, FBG, GMR, BSE, ASB, JRV, CRM, BEM), R21HL118637 (TW, BEM, TG). GMR was also supported by the FONDECYT-Chile (grants 1100131 and 1130392). ASB was supported by the Dalglish Chair in 22q11.2 Deletion Syndrome, the Canada Research Chair in Schizophrenia Genetics and Genomic Disorders, Canadian Institutes of Health Research funding (MOP-97800 and MOP-89066), and the University of Toronto McLaughlin Centre. CEB was supported by the NIH (R01 MH085903). SE was supported by the Swiss National Science Foundation (FNS 324730_121996; FNS 324730_144260). JV was supported by the Flemish Science Foundation (FWO G.0E1117N).
Funding Information:
We would like to thank the families with 22q11.2DS who provided DNA and clinical information. We acknowledge the Genomics and Molecular Cytogenetics Cores at Einstein. We also acknowledge Mark Zeffren, Nousin Haque and Antoneta Preldakaj for project management and John Bruppacher, Dan Arroyo, Michael Gleeson, Dominique Calandrillo and Fr?d?rique Bena for technical support at Einstein. We also greatly appreciate the laboratory effort of Dr. Fr?d?rique Bena who works with SE and SEA (Institute of Genetics and Genomics of Geneva, Switzerland). NIH R01 HL084410 (BSE, BEM, DMM, TG, TW), P01 HD070454 (BSE, BEM, DMM, TG, TW, HN, LZ, DZ, YZ, TBC), U01 MH101720 (TG, AD, DMM, MH, WD, YZ, FU, LK-W, CEB, WRK, DG, MS, SE, JB, AS, JV, FBG, GMR, BSE, ASB, JRV, CRM, BEM), R21HL118637 (TW, BEM, TG). GMR was also supported by the FONDECYT-Chile (grants 1100131 and 1130392). ASB was supported by the Dalglish Chair in 22q11.2 Deletion Syndrome, the Canada Research Chair in Schizophrenia Genetics and Genomic Disorders, Canadian Institutes of Health Research funding (MOP-97800 and MOP-89066), and the University of Toronto McLaughlin Centre. CEB was supported by the NIH (R01 MH085903). SE was supported by the Swiss National Science Foundation (FNS 324730_121996; FNS 324730_144260). JV was supported by the Flemish Science Foundation (FWO G.0E1117N).
Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press. All rights reserved.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Recurrent, de novo, meiotic non-allelic homologous recombination events between low copy repeats, termed LCR22s, leads to the 22q11.2 deletion syndrome (22q11.2DS; velo-cardio-facial syndrome/DiGeorge syndrome). Although most 22q11.2DS patients have a similar sized 3 million base pair (Mb), LCR22A-D deletion, some have nested LCR22A-B or LCR22A-C deletions. Our goal is to identify additional recurrent 22q11.2 deletions associated with 22q11.2DS, serving as recombination hotspots for meiotic chromosomal rearrangements. Here, using data from Affymetrix 6.0 microarrays on 1680 22q11.2DS subjects, we identified what appeared to be a nested proximal 22q11.2 deletion in 38 (2.3%) of them. Using molecular and haplotype analyses from 14 subjects and their parent(s) with available DNA, we found essentially three types of scenarios to explain this observation. In eight subjects, the proximal breakpoints occurred in a small sized 12 kb LCR distal to LCR22A, referred to LCR22A+, resulting in LCR22A+-B or LCR22A+-D deletions. Six of these eight subjects had a nested 22q11.2 deletion that occurred during meiosis in a parent carrying a benign 0.2 Mb duplication of the LCR22A-LCR22A+region with a breakpoint in LCR22A+. Another six had a typical de novo LCR22A-D deletion on one allele and inherited the LCR22A-A+duplication from the other parent thus appearing on microarrays to have a nested deletion. LCR22A+maps to an evolutionary breakpoint between mice and humans and appears to serve as a local hotspot for chromosome rearrangements on 22q11.2.
AB - Recurrent, de novo, meiotic non-allelic homologous recombination events between low copy repeats, termed LCR22s, leads to the 22q11.2 deletion syndrome (22q11.2DS; velo-cardio-facial syndrome/DiGeorge syndrome). Although most 22q11.2DS patients have a similar sized 3 million base pair (Mb), LCR22A-D deletion, some have nested LCR22A-B or LCR22A-C deletions. Our goal is to identify additional recurrent 22q11.2 deletions associated with 22q11.2DS, serving as recombination hotspots for meiotic chromosomal rearrangements. Here, using data from Affymetrix 6.0 microarrays on 1680 22q11.2DS subjects, we identified what appeared to be a nested proximal 22q11.2 deletion in 38 (2.3%) of them. Using molecular and haplotype analyses from 14 subjects and their parent(s) with available DNA, we found essentially three types of scenarios to explain this observation. In eight subjects, the proximal breakpoints occurred in a small sized 12 kb LCR distal to LCR22A, referred to LCR22A+, resulting in LCR22A+-B or LCR22A+-D deletions. Six of these eight subjects had a nested 22q11.2 deletion that occurred during meiosis in a parent carrying a benign 0.2 Mb duplication of the LCR22A-LCR22A+region with a breakpoint in LCR22A+. Another six had a typical de novo LCR22A-D deletion on one allele and inherited the LCR22A-A+duplication from the other parent thus appearing on microarrays to have a nested deletion. LCR22A+maps to an evolutionary breakpoint between mice and humans and appears to serve as a local hotspot for chromosome rearrangements on 22q11.2.
UR - http://www.scopus.com/inward/record.url?scp=85044844068&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044844068&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddy028
DO - 10.1093/hmg/ddy028
M3 - Article
C2 - 29361080
AN - SCOPUS:85044844068
SN - 0964-6906
VL - 27
SP - 1150
EP - 1163
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 7
ER -